Market Research Report
Global Xerostomia Therapeutics Market 2019-2023
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||762828|
|Published||Content info||112 Pages
Delivery time: 1-2 business days
|Global Xerostomia Therapeutics Market 2019-2023|
|Published: December 7, 2018||Content info: 112 Pages||
The most common disease that causes xerostomia is an inflammatory autoimmune disease. Additionally, central nervous system- related diseases including stress, depression, and anxiety can also lead to xerostomia. Moreover, trauma to the head and neck area can alter the nerve stimuli to the mouth and impair the function to the salivary glands. Therefore, the rising incidence of the health conditions or diseases that are high- risk factors for xerostomia is expected to continue to support the growth of the global xerostomia therapeutics market during the forecast period. According to our industry experts, the xerostomia therapeutics market to grow at a CAGR of over 3% during the forecast period.
The increasing number of people with xerostomia is directly related to the growing geriatric population. The number of old people worldwide has been growing significantly over the years. This expected to contribute significantly to the market as this high growth in the older population helps to drive the sales of various therapeutics markets during our forecast period.
Regulatory bodies have framed stringent regulations to grant marketing approval for therapeutics that are being newly developed for the treatment of xerostomia. Many applications rejected either due to the inadequate performance of the drug or because the information on the drug, which is submitted is unsatisfactory. Such stringent government regulations can lead to a delay in drug in drug approval which in turn hampers the growth of the market.
For the detailed list of factors that will drive and challenge the growth of the xerostomia therapeutics market during the 2019-2023, view our report.
The xerostomia therapeutics market is fragmented due to presence of many vendors in the market. The pharmaceutical companies are forming strategic collaborations which will enhance the R&D activities for new drugs for the management xerostomia. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.